Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis.

Méndez-Barbero N, Gutierrez-Muñoz C, Madrigal-Matute J, Mínguez P, Egido J, Michel JB, Martín-Ventura JL, Esteban V, Blanco-Colio LM.

EBioMedicine. 2019 Aug 5. pii: S2352-3964(19)30514-6. doi: 10.1016/j.ebiom.2019.07.072. [Epub ahead of print]

2.

Role of complement system in pathological remodeling of the vascular wall.

Martin-Ventura JL, Martinez-Lopez D, Roldan-Montero R, Gomez-Guerrero C, Blanco-Colio LM.

Mol Immunol. 2019 Jul 31;114:207-215. doi: 10.1016/j.molimm.2019.06.016. [Epub ahead of print] Review.

PMID:
31377677
3.

APOA1 oxidation is associated to dysfunctional high-density lipoproteins in human abdominal aortic aneurysm.

Martínez-López D, Camafeita E, Cedó L, Roldan-Montero R, Jorge I, García-Marqués F, Gómez-Serrano M, Bonzon-Kulichenko E, Blanco-Vaca F, Blanco-Colio LM, Michel JB, Escola-Gil JC, Vázquez J, Martin-Ventura JL.

EBioMedicine. 2019 May;43:43-53. doi: 10.1016/j.ebiom.2019.04.012. Epub 2019 Apr 11.

4.

Pathophisiology of abdominal aortic aneurysm: biomarkers and novel therapeutic targets.

Torres-Fonseca M, Galan M, Martinez-Lopez D, Cañes L, Roldan-Montero R, Alonso J, Reyero-Postigo T, Orriols M, Mendez-Barbero N, Sirvent M, Blanco-Colio LM, Martínez J, Martin-Ventura JL, Rodríguez C; En representación del Grupo de trabajo de Biología Vascular de la Sociedad Española de Arteriosclerosis.

Clin Investig Arterioscler. 2019 Jul - Aug;31(4):166-177. doi: 10.1016/j.arteri.2018.10.002. Epub 2018 Dec 7. Review. English, Spanish.

PMID:
30528271
5.

Impaired HDL (High-Density Lipoprotein)-Mediated Macrophage Cholesterol Efflux in Patients With Abdominal Aortic Aneurysm-Brief Report.

Martínez-López D, Cedó L, Metso J, Burillo E, García-León A, Canyelles M, Lindholt JS, Torres-Fonseca M, Blanco-Colio LM, Vázquez J, Blanco-Vaca F, Jauhiainen M, Martín-Ventura JL, Escolà-Gil JC.

Arterioscler Thromb Vasc Biol. 2018 Nov;38(11):2750-2754. doi: 10.1161/ATVBAHA.118.311704.

PMID:
30354236
6.

Lipocalin-2, a potential therapeutic target in advanced atherosclerosis.

Fernandez-García CE, Roldan-Montero R, Tarin C, Martinez-Lopez D, Pastor-Vargas C, Blanco-Colio LM, Martín-Ventura JL.

Atherosclerosis. 2018 Nov;278:321-322. doi: 10.1016/j.atherosclerosis.2018.07.036. Epub 2018 Jul 27. No abstract available.

PMID:
30170736
7.

Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease.

Bozic M, Méndez-Barbero N, Gutiérrez-Muñoz C, Betriu A, Egido J, Fernández E, Martín-Ventura JL, Valdivielso JM, Blanco-Colio LM; investigators from the NEFRONA study.

Atherosclerosis. 2018 Mar;270:13-20. doi: 10.1016/j.atherosclerosis.2018.01.011. Epub 2018 Feb 4.

PMID:
29407881
8.

Oxidative Stress in Human Atherothrombosis: Sources, Markers and Therapeutic Targets.

Martin-Ventura JL, Rodrigues-Diez R, Martinez-Lopez D, Salaices M, Blanco-Colio LM, Briones AM.

Int J Mol Sci. 2017 Nov 3;18(11). pii: E2315. doi: 10.3390/ijms18112315. Review.

9.

Increased galectin-3 levels are associated with abdominal aortic aneurysm progression and inhibition of galectin-3 decreases elastase-induced AAA development.

Fernandez-García CE, Tarin C, Roldan-Montero R, Martinez-Lopez D, Torres-Fonseca M, Lindhot JS, Vega de Ceniga M, Egido J, Lopez-Andres N, Blanco-Colio LM, Martín-Ventura JL.

Clin Sci (Lond). 2017 Nov 6;131(22):2707-2719. doi: 10.1042/CS20171142. Print 2017 Nov 15.

PMID:
28982723
10.

TWEAK blockade decreases atherosclerotic lesion size and progression through suppression of STAT1 signaling in diabetic mice.

Fernández-Laso V, Sastre C, Méndez-Barbero N, Egido J, Martín-Ventura JL, Gómez-Guerrero C, Blanco-Colio LM.

Sci Rep. 2017 Apr 27;7:46679. doi: 10.1038/srep46679.

11.

Soluble TWEAK and atheromatosis progression in patients with chronic kidney disease.

Fernández-Laso V, Méndez-Barbero N, Valdivielso JM, Betriu A, Fernández E, Egido J, Martín-Ventura JL, Blanco-Colio LM.

Atherosclerosis. 2017 May;260:130-137. doi: 10.1016/j.atherosclerosis.2017.03.043. Epub 2017 Mar 31.

PMID:
28390291
12.

Association of ficolin-3 with abdominal aortic aneurysm presence and progression.

Fernandez-García CE, Burillo E, Lindholt JS, Martinez-Lopez D, Pilely K, Mazzeo C, Michel JB, Egido J, Garred P, Blanco-Colio LM, Martin-Ventura JL.

J Thromb Haemost. 2017 Mar;15(3):575-585. doi: 10.1111/jth.13608. Epub 2017 Feb 15.

13.

Quantitative HDL Proteomics Identifies Peroxiredoxin-6 as a Biomarker of Human Abdominal Aortic Aneurysm.

Burillo E, Jorge I, Martínez-López D, Camafeita E, Blanco-Colio LM, Trevisan-Herraz M, Ezkurdia I, Egido J, Michel JB, Meilhac O, Vázquez J, Martin-Ventura JL.

Sci Rep. 2016 Dec 9;6:38477. doi: 10.1038/srep38477.

14.

Proteomics and metabolomics in biomarker discovery for cardiovascular diseases: progress and potential.

Tuñón J, Barbas C, Blanco-Colio L, Burillo E, Lorenzo Ó, Martín-Ventura JL, Más S, Rupérez FJ, Egido J.

Expert Rev Proteomics. 2016 Sep;13(9):857-71. doi: 10.1080/14789450.2016.1217775. Epub 2016 Aug 5. Review.

PMID:
27459711
15.

Parathormone Levels Are Independently Associated with the Presence of Left Ventricular Hypertrophy in Patients with Coronary Artery Disease.

Aceña Á, Pello AM, Carda R, Lorenzo Ó, Gonzalez-Casaus ML, Blanco-Colio LM, Martín-Ventura JL, Palfy J, Orejas M, Rábago R, Gonzalez-Parra E, Mahíllo-Fernández I, Farré J, Egido J, Tuñón J.

J Nutr Health Aging. 2016;20(6):659-64. doi: 10.1007/s12603-015-0649-y.

PMID:
27273357
16.

Lipocalin-2 deficiency or blockade protects against aortic abdominal aneurysm development in mice.

Tarín C, Fernandez-Garcia CE, Burillo E, Pastor-Vargas C, Llamas-Granda P, Castejón B, Ramos-Mozo P, Torres-Fonseca MM, Berger T, Mak TW, Egido J, Blanco-Colio LM, Martín-Ventura JL.

Cardiovasc Res. 2016 Aug 1;111(3):262-73. doi: 10.1093/cvr/cvw112. Epub 2016 May 26.

PMID:
27229458
17.

Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease.

Martín-Reyes R, Franco-Peláez JA, Lorenzo Ó, González-Casaus ML, Pello AM, Aceña Á, Carda R, Martín-Ventura JL, Blanco-Colio L, Martín-Mariscal ML, Martínez-Milla J, Villa-Bellosta R, Piñero A, Navarro F, Egido J, Tuñón J.

PLoS One. 2016 May 12;11(5):e0152816. doi: 10.1371/journal.pone.0152816. eCollection 2016.

18.

Paraoxonase-1 overexpression prevents experimental abdominal aortic aneurysm progression.

Burillo E, Tarin C, Torres-Fonseca MM, Fernandez-García CE, Martinez-Pinna R, Martinez-Lopez D, Llamas-Granda P, Camafeita E, Lopez JA, Vega de Ceniga M, Aviram M, Egido J, Blanco-Colio LM, Martín-Ventura JL.

Clin Sci (Lond). 2016 Jun 1;130(12):1027-38. doi: 10.1042/CS20160185. Epub 2016 Mar 18.

PMID:
26993251
19.

Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.

Fernández-Laso V, Sastre C, Valdivielso JM, Betriu A, Fernández E, Egido J, Martín-Ventura JL, Blanco-Colio LM.

Clin J Am Soc Nephrol. 2016 Mar 7;11(3):413-22. doi: 10.2215/CJN.07900715. Epub 2016 Jan 4.

20.

Targeted gold-coated iron oxide nanoparticles for CD163 detection in atherosclerosis by MRI.

Tarin C, Carril M, Martin-Ventura JL, Markuerkiaga I, Padro D, Llamas-Granda P, Moreno JA, García I, Genicio N, Plaza-Garcia S, Blanco-Colio LM, Penades S, Egido J.

Sci Rep. 2015 Nov 30;5:17135. doi: 10.1038/srep17135.

21.

Hemoglobin induces monocyte recruitment and CD163-macrophage polarization in abdominal aortic aneurysm.

Rubio-Navarro A, Amaro Villalobos JM, Lindholt JS, Buendía I, Egido J, Blanco-Colio LM, Samaniego R, Meilhac O, Michel JB, Martín-Ventura JL, Moreno JA.

Int J Cardiol. 2015 Dec 15;201:66-78. doi: 10.1016/j.ijcard.2015.08.053. Epub 2015 Aug 6.

PMID:
26296046
22.

TWEAK/Fn14 interaction promotes oxidative stress through NADPH oxidase activation in macrophages.

Madrigal-Matute J, Fernandez-Laso V, Sastre C, Llamas-Granda P, Egido J, Martin-Ventura JL, Zalba G, Blanco-Colio LM.

Cardiovasc Res. 2015 Oct 1;108(1):139-47. doi: 10.1093/cvr/cvv204. Epub 2015 Jul 29.

PMID:
26224570
23.

Thioredoxin-1/peroxiredoxin-1 as sensors of oxidative stress mediated by NADPH oxidase activity in atherosclerosis.

Madrigal-Matute J, Fernandez-Garcia CE, Blanco-Colio LM, Burillo E, Fortuño A, Martinez-Pinna R, Llamas-Granda P, Beloqui O, Egido J, Zalba G, Martin-Ventura JL.

Free Radic Biol Med. 2015 Sep;86:352-61. doi: 10.1016/j.freeradbiomed.2015.06.001. Epub 2015 Jun 24.

PMID:
26117319
24.

N-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery Disease.

Tuñón J, Higueras J, Tarín N, Cristóbal C, Lorenzo Ó, Blanco-Colio L, Martín-Ventura JL, Huelmos A, Alonso J, Aceña Á, Pello A, Carda R, Asensio D, Mahíllo-Fernández I, López Bescós L, Egido J, Farré J.

PLoS One. 2015 Jun 5;10(6):e0126741. doi: 10.1371/journal.pone.0126741. eCollection 2015.

25.

The Prognostic Value of High-Sensitive Troponin I in Stable Coronary Artery Disease Depends on Age and Other Clinical Variables.

Carda R, Aceña Á, Pello A, Cristóbal C, Tarín N, Huelmos A, Alonso J, Asensio D, Lorenzo Ó, Martín-Ventura JL, Blanco-Colio L, Farré J, López Bescós L, Egido J, Tuñón J.

Cardiology. 2015;132(1):1-8. doi: 10.1159/000381259. Epub 2015 May 14.

26.

ApoA-I/HDL-C levels are inversely associated with abdominal aortic aneurysm progression.

Burillo E, Lindholt JS, Molina-Sánchez P, Jorge I, Martinez-Pinna R, Blanco-Colio LM, Tarin C, Torres-Fonseca MM, Esteban M, Laustsen J, Ramos-Mozo P, Calvo E, Lopez JA, Vega de Ceniga M, Michel JB, Egido J, Andrés V, Vazquéz J, Meilhac O, Martin-Ventura JL.

Thromb Haemost. 2015 Jun;113(6):1335-46. doi: 10.1160/TH14-10-0874. Epub 2015 Mar 19.

PMID:
25789510
27.

Soluble TWEAK levels predict the presence of carotid atherosclerotic plaques in subjects free from clinical cardiovascular diseases.

Fernández-Laso V, Sastre C, Valdivielso JM, Fernández E, Martín-Ventura JL, Egido J, Blanco-Colio LM.

Atherosclerosis. 2015 Apr;239(2):358-63. doi: 10.1016/j.atherosclerosis.2015.01.040. Epub 2015 Feb 7.

PMID:
25681674
28.

Differential profile in inflammatory and mineral metabolism biomarkers in patients with ischemic heart disease without classical coronary risk factors.

Pello AM, Cristóbal C, Tarín N, Huelmos A, Aceña Á, Carda R, González-Casaus ML, Alonso J, Lorenzo Ó, Blanco-Colio L, Martín-Ventura JL, Franco Peláez JA, Mahíllo-Fernández I, Farré J, López-Bescós L, Egido J, Tuñón J.

J Cardiol. 2015 Jul;66(1):22-7. doi: 10.1016/j.jjcc.2014.11.006. Epub 2014 Dec 19.

29.

[Impact of plasma pro-B-type natriuretic peptide amino-terminal and galectin-3 levels on the predictive capacity of the LIPID Clinical Risk Scale in stable coronary disease].

Higueras J, Martín-Ventura JL, Blanco-Colio L, Cristóbal C, Tarín N, Huelmos A, Alonso J, Pello A, Aceña Á, Carda R, Lorenzo Ó, Mahíllo-Fernández I, Asensio D, Almeida P, Rodríguez-Artalejo F, Farré J, López Bescós L, Egido J, Tuñón J.

Clin Investig Arterioscler. 2015 Mar-Apr;27(2):57-63. doi: 10.1016/j.arteri.2014.06.003. Epub 2014 Aug 13. Spanish.

PMID:
25127747
30.

Galectin-3, a biomarker linking oxidative stress and inflammation with the clinical outcomes of patients with atherothrombosis.

Madrigal-Matute J, Lindholt JS, Fernandez-Garcia CE, Benito-Martin A, Burillo E, Zalba G, Beloqui O, Llamas-Granda P, Ortiz A, Egido J, Blanco-Colio LM, Martin-Ventura JL.

J Am Heart Assoc. 2014 Aug 5;3(4). pii: e000785. doi: 10.1161/JAHA.114.000785.

31.

Tumor necrosis factor-like weak inducer of apoptosis or Fn14 deficiency reduce elastase perfusion-induced aortic abdominal aneurysm in mice.

Tarín C, Fernández-Laso V, Sastre C, Madrigal-Matute J, Gómez M, Zaragoza C, Egido J, Burkly LC, Martín-Ventura JL, Blanco-Colio LM.

J Am Heart Assoc. 2014 Aug 4;3(4). pii: e000723. doi: 10.1161/JAHA.113.000723. Erratum in: J Am Heart Assoc. 2014 Oct;3(5):000509.

32.

[Atorvastatin inhibits the atherosclerotic lesion induced by tumor necrosis factor-like weak inducer of apoptosis in apolipoprotein E deficient mice].

Fernández-Laso V, Sastre C, Egido J, Martín-Ventura JL, Blanco-Colio LM.

Clin Investig Arterioscler. 2015 Jan-Feb;27(1):17-25. doi: 10.1016/j.arteri.2014.04.003. Epub 2014 Jul 12. Spanish.

PMID:
25027757
33.

Label-free proteomic analysis of red blood cell membrane fractions from abdominal aortic aneurysm patients.

Martinez-Pinna R, Burillo E, Madrigal-Matute J, Lopez JA, Camafeita E, Torres-Fonseca MM, Llamas-Granda P, Egido J, Michel JB, Blanco-Colio LM, Martin-Ventura JL.

Proteomics Clin Appl. 2014 Aug;8(7-8):626-30. doi: 10.1002/prca.201400035.

PMID:
24976601
34.

Phase IV prospective clinical study to evaluate the effect of taurine on liver function in postsurgical adult patients requiring parenteral nutrition.

Arrieta F, Balsa JA, de la Puerta C, Botella JI, Zamarrón I, Elías E, Del Río JI, Alonso P, Candela A, Blanco-Colio LM, Egido J, Navarro P, Vázquez C.

Nutr Clin Pract. 2014 Oct;29(5):672-80. doi: 10.1177/0884533614533610. Epub 2014 May 14.

PMID:
24829298
35.

Assessment of biomarkers and predictive model for short-term prospective abdominal aortic aneurysm growth-A pilot study.

Vega de Ceniga M, Esteban M, Barba A, Estallo L, Blanco-Colio LM, Martin-Ventura JL.

Ann Vasc Surg. 2014 Oct;28(7):1642-8. doi: 10.1016/j.avsg.2014.02.025. Epub 2014 Mar 12.

PMID:
24632318
36.

From tissue iron retention to low systemic haemoglobin levels, new pathophysiological biomarkers of human abdominal aortic aneurysm.

Martinez-Pinna R, Lindholt JS, Madrigal-Matute J, Blanco-Colio LM, Esteban-Salan M, Torres-Fonseca MM, Lefebvre T, Delbosc S, Laustsen J, Driss F, Vega de Ceniga M, Gouya L, Weiss G, Egido J, Meilhac O, Michel JB, Martin-Ventura J.

Thromb Haemost. 2014 Jul 3;112(1):87-95. doi: 10.1160/TH13-08-0721. Epub 2014 Mar 6.

PMID:
24599423
37.

TWEAK promotes peritoneal inflammation.

Sanz AB, Aroeira LS, Bellon T, del Peso G, Jimenez-Heffernan J, Santamaria B, Sanchez-Niño MD, Blanco-Colio LM, Lopez-Cabrera M, Ruiz-Ortega M, Egido J, Selgas R, Ortiz A.

PLoS One. 2014 Mar 5;9(3):e90399. doi: 10.1371/journal.pone.0090399. eCollection 2014.

38.

Reduced sTWEAK and increased sCD163 levels in HIV-infected patients: modulation by antiretroviral treatment, HIV replication and HCV co-infection.

Beltrán LM, Muñoz Hernández R, de Pablo Bernal RS, García Morillo JS, Egido J, Noval ML, Ferrando-Martinez S, Blanco-Colio LM, Genebat M, Villar JR, Moreno-Luna R, Moreno JA.

PLoS One. 2014 Mar 4;9(3):e90541. doi: 10.1371/journal.pone.0090541. eCollection 2014.

39.

Genetic deletion or TWEAK blocking antibody administration reduce atherosclerosis and enhance plaque stability in mice.

Sastre C, Fernández-Laso V, Madrigal-Matute J, Muñoz-García B, Moreno JA, Pastor-Vargas C, Llamas-Granda P, Burkly LC, Egido J, Martín-Ventura JL, Blanco-Colio LM.

J Cell Mol Med. 2014 Apr;18(4):721-34. doi: 10.1111/jcmm.12221. Epub 2014 Jan 30.

40.

TWEAK/Fn14 Axis: A Promising Target for the Treatment of Cardiovascular Diseases.

Blanco-Colio LM.

Front Immunol. 2014 Jan 20;5:3. doi: 10.3389/fimmu.2014.00003. eCollection 2014. Review.

41.

Hyperlipidemia-associated renal damage decreases Klotho expression in kidneys from ApoE knockout mice.

Sastre C, Rubio-Navarro A, Buendía I, Gómez-Guerrero C, Blanco J, Mas S, Egido J, Blanco-Colio LM, Ortiz A, Moreno JA.

PLoS One. 2013 Dec 30;8(12):e83713. doi: 10.1371/journal.pone.0083713. eCollection 2013.

42.

Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease.

Tuñón J, Blanco-Colio L, Cristóbal C, Tarín N, Higueras J, Huelmos A, Alonso J, Egido J, Asensio D, Lorenzo Ó, Mahíllo-Fernández I, Rodríguez-Artalejo F, Farré J, Martín-Ventura JL, López-Bescós L.

Am J Cardiol. 2014 Feb 1;113(3):434-40. doi: 10.1016/j.amjcard.2013.10.012. Epub 2013 Nov 7.

PMID:
24295549
43.

Soluble TWEAK plasma levels increase after renal transplantation and associate with the improvement of endothelial function.

Yilmaz MI, Sonmez A, Saglam M, Yaman H, Unal HU, Gok M, Cetinkaya H, Eyileten T, Oguz Y, Sari S, Yildirim AO, Vural A, Carrero JJ, Blanco-Colio LM.

Eur J Clin Invest. 2013 Dec;43(12):1250-7. doi: 10.1111/eci.12166. Epub 2013 Sep 20.

PMID:
24112080
44.

Proteomic analysis of intraluminal thrombus highlights complement activation in human abdominal aortic aneurysms.

Martinez-Pinna R, Madrigal-Matute J, Tarin C, Burillo E, Esteban-Salan M, Pastor-Vargas C, Lindholt JS, Lopez JA, Calvo E, de Ceniga MV, Meilhac O, Egido J, Blanco-Colio LM, Michel JB, Martin-Ventura JL.

Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):2013-20. doi: 10.1161/ATVBAHA.112.301191. Epub 2013 May 23.

PMID:
23702661
45.

Identification of novel biomarkers of abdominal aortic aneurysms by 2D-DIGE and MALDI-MS from AAA-thrombus-conditioned media.

Martinez-Pinna R, Lopez JA, Ramos-Mozo P, Blanco-Colio LM, Camafeita E, Calvo E, Meilhac O, Michel JB, Egido J, Martin-Ventura JL.

Methods Mol Biol. 2013;1000:91-101. doi: 10.1007/978-1-62703-405-0_8.

PMID:
23585087
46.

Soluble TWEAK is associated with atherosclerotic burden in patients with chronic kidney disease.

Valdivielso JM, Coll B, Martín-Ventura JL, Moreno JA, Egido J, Fernández E, Blanco-Colio LM.

J Nephrol. 2013 Nov-Dec;26(6):1105-13. doi: 10.5301/jn.5000245. Epub 2013 Jan 28.

PMID:
23475462
47.

HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in atherosclerotic plaques and cultured monocytes.

Moreno JA, Sastre C, Madrigal-Matute J, Muñoz-García B, Ortega L, Burkly LC, Egido J, Martín-Ventura JL, Blanco-Colio LM.

Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):612-20. doi: 10.1161/ATVBAHA.112.300874. Epub 2013 Jan 3.

PMID:
23288170
48.

Oxidative stress, macrophage infiltration and CD163 expression are determinants of long-term renal outcome in macrohematuria-induced acute kidney injury of IgA nephropathy.

Gutiérrez E, Egido J, Rubio-Navarro A, Buendía I, Blanco Colio LM, Toldos O, Manzarbeitia F, de Lorenzo A, Sanchez R, Ortiz A, Praga M, Moreno JA.

Nephron Clin Pract. 2012;121(1-2):c42-53. doi: 10.1159/000342385. Epub 2012 Oct 19.

PMID:
23095372
49.

Erythrocytes, leukocytes and platelets as a source of oxidative stress in chronic vascular diseases: detoxifying mechanisms and potential therapeutic options.

Martin-Ventura JL, Madrigal-Matute J, Martinez-Pinna R, Ramos-Mozo P, Blanco-Colio LM, Moreno JA, Tarin C, Burillo E, Fernandez-Garcia CE, Egido J, Meilhac O, Michel JB.

Thromb Haemost. 2012 Sep;108(3):435-42. doi: 10.1160/TH12-04-0248. Epub 2012 Jul 26. Review.

PMID:
22836558
50.

Targeting chemokines in proteinuria-induced renal disease.

Moreno JA, Moreno S, Rubio-Navarro A, Sastre C, Blanco-Colio LM, Gómez-Guerrero C, Ortiz A, Egido J.

Expert Opin Ther Targets. 2012 Aug;16(8):833-45. doi: 10.1517/14728222.2012.703657. Review.

PMID:
22793382

Supplemental Content

Loading ...
Support Center